Stefan Lohse

2.1k total citations
42 papers, 1.2k citations indexed

About

Stefan Lohse is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Stefan Lohse has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Molecular Biology and 18 papers in Immunology. Recurrent topics in Stefan Lohse's work include Monoclonal and Polyclonal Antibodies Research (21 papers), Glycosylation and Glycoproteins Research (12 papers) and Immune Cell Function and Interaction (7 papers). Stefan Lohse is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (21 papers), Glycosylation and Glycoproteins Research (12 papers) and Immune Cell Function and Interaction (7 papers). Stefan Lohse collaborates with scholars based in Germany, Netherlands and Russia. Stefan Lohse's co-authors include Thomas Valerius, Matthias Peipp, Stefanie Derer, Michael Dechant, Sven Berger, Sigrun Smola, Jan G. J. van de Winkel, Thomas Beyer, Katja Klausz and Jeanette H.W. Leusen and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Stefan Lohse

38 papers receiving 1.1k citations

Peers

Countries citing papers authored by Stefan Lohse

Since Specialization

Citations

This map shows the geographic impact of Stefan Lohse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Lohse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Lohse more than expected).

Fields of papers citing papers by Stefan Lohse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Lohse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Lohse. The network helps show where Stefan Lohse may publish in the future.

Co-authorship network of co-authors of Stefan Lohse

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Lohse. A scholar is included among the top collaborators of Stefan Lohse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Lohse. Stefan Lohse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of Nectin-4 and Trop-2: Implications for Patient Outcomes and Therapy in Penile Cancer 2025 ·Modern Pathology ·(unknown), Markus Eckstein, (unknown), Alexey Pryalukhin, Carol I. Geppert, Stefan Lohse, (unknown), João Lobo, Rui Henrique, Hagen Loertzer, J. Steffens, Cármen Jerónimo, Heiko Wunderlich, Julia Heinzelbecker, Rainer M. Bohle, Michael Stöckle, В. Б. Матвеев, Arndt Hartmann, Kerstin Junker	2
2	The impact of the tumor microenvironment on the survival of penile cancer patients 2024 ·Scientific Reports ·Stefan Lohse, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), В. Б. Матвеев, (unknown), Alexey Pryalukhin, Arndt Hartmann, Carol‐Immanuel Geppert, Hagen Loertzer, Heiko Wunderlich, Hans‐Peter Lenhof, Carsten Maik Naumann, Holger Kalthoff, Kerstin Junker	3
3	The tumor cell killing capacity of head and neck cancer patient-derived neutrophils depends on tumor stage, gender and the antibody isotype 2024 ·Oral Oncology ·(unknown), (unknown), (unknown), Maximilian Linxweiler, Stefan Lohse	0
4	Evaluation of Prognostic Parameters to Identify Aggressive Penile Carcinomas 2023 ·Cancers ·(unknown), (unknown), Alexey Pryalukhin, Carol Geppert, Stefan Lohse, (unknown), João Lobo, Rui Henrique, Hagen Loertzer, J. Steffens, Cármen Jerónimo, Heiko Wunderlich, Julia Heinzelbecker, Rainer M. Bohle, Michael Stöckle, В. Б. Матвеев, Arndt Hartmann, Kerstin Junker	3
5	Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2 2022 ·Expert Review of Vaccines ·Igor Age Kos, (unknown), (unknown), (unknown), Joerg Thomas Bittenbring, Manfred Ahlgrimm, Sigrun Smola, Stefan Lohse, Konstantinos Christofyllakis, Dominic Kaddu‐Mulindwa, Frank Neumann, Moritz Bewarder, Lorenz Thurner	1
6	Rapid Base-Specific Calling of SARS-CoV-2 Variants of Concern Using Combined RT-PCR Melting Curve Screening and SIRPH Technology 2021 ·Open Forum Infectious Diseases ·Sascha Tierling, Kathrin Kattler, (unknown), Thorsten Pfuhl, Stefan Lohse, (unknown), B. Schmitt, (unknown), Abdulrahman Salhab, Sigrun Smola, Jörn Walter	4
7	IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study 2021 ·HIV Medicine ·Dominic Kaddu‐Mulindwa, (unknown), (unknown), Jürgen Rissland, Sigrun Smola, (unknown), Stephan Stilgenbauer, Konstantinos Christofyllakis, Lorenz Thurner, Moritz Bewarder, (unknown), Jens Lutz, Stefan Lohse, Ansgar Rieke	3
8	The HPV and p63 Status in Penile Cancer Are Linked with the Infiltration and Therapeutic Availability of Neutrophils 2020 ·Molecular Cancer Therapeutics ·(unknown), (unknown), (unknown), Gilles Gasparoni, (unknown), В. Б. Матвеев, (unknown), Alexey Pryalukhin, Arndt Hartmann, Carol‐Immanuel Geppert, Hagen Loertzer, Heiko Wunderlich, Carsten Maik Naumann, Holger Kalthoff, Kerstin Junker, Sigrun Smola, Stefan Lohse	8
9	Monitoring kinetics reveals critical parameters of IgA-dependent granulocyte-mediated anti-tumor cell cytotoxicity 2019 ·Journal of Immunological Methods ·(unknown), (unknown), (unknown), Maximilian Linxweiler, Bernhard Schick, Joana Heinzelmann, Sigrun Smola, Stefan Lohse	7
10	Chronic Inflammatory Microenvironment in Epidermodysplasia Verruciformis Skin Lesions: Role of the Synergism Between HPV8 E2 and C/EBPβ to Induce Pro-Inflammatory S100A8/A9 Proteins 2018 ·Frontiers in Microbiology ·Marta Podgórska, Monika Ołdak, (unknown), (unknown), Barbara Walch‐Rückheim, Stefan Lohse, F. Max Müller, Thomas Vogt, Mart Ustav, Artur Wnorowski, Magdalena Malejczyk, Sławomir Majewski, Sigrun Smola	15
11	An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo 2015 ·Cancer Research ·Stefan Lohse, Saskia Meyer, Laura A.P.M. Meulenbroek, J.H. Marco Jansen, Maaike Nederend, (unknown), Katja Klausz, Uwe Möginger, Stefanie Derer, Thies Rösner, Christian Kellner, Denis M. Schewe, Peter Sondermann, Sanjay Tiwari, Daniel Kolarich, Matthias Peipp, Jeanette H.W. Leusen, Thomas Valerius	62
12	HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity 2015 ·Oncotarget ·Matthias Peipp, Stefanie Derer, Stefan Lohse, (unknown), Katja Klausz, Thomas Valerius, Martin Gramatzki, Christian Kellner	31
13	Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing 2015 ·Cancer Immunology Research ·Arianne M. Brandsma, Toine ten Broeke, Maaike Nederend, Laura A.P.M. Meulenbroek, Geert van Tetering, Saskia Meyer, J.H. Marco Jansen, (unknown), Sietse Q. Nagelkerke, István Balázs Németh, Ruud Ubink, Gerard Rouwendal, Stefan Lohse, Thomas Valerius, Jeanette H.W. Leusen, Péter Boross	39
14	Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicity 2013 ·mAbs ·Stefanie Derer, (unknown), (unknown), Stefan Lohse, Katja Klausz, Umesh S. Muchhal, John R. Desjarlais, Andreas Humpe, Thomas Valerius, Matthias Peipp	46
15	Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2 m(1) antibody 2013 ·mAbs ·(unknown), Stefan Lohse, Stefanie Derer, Matthias Peipp, Péter Boross, Christian Kellner, Thomas Beyer, Michael Dechant, Louise Royle, Li Phing Liew, Jeanette H.W. Leusen, Thomas Valerius	17
16	Ig A EGFR antibodies mediate tumour killing in vivo 2013 ·EMBO Molecular Medicine ·Péter Boross, Stefan Lohse, Maaike Nederend, J.H. Marco Jansen, Geert van Tetering, Michael Dechant, Matthias Peipp, Louise Royle, Li Phing Liew, Louis Boon, Nico van Rooijen, Wim K. Bleeker, Paul W.H.I. Parren, Jan G. J. van de Winkel, Thomas Valerius, Jeanette H.W. Leusen	101
17	Impact of Epidermal Growth Factor Receptor (EGFR) Cell Surface Expression Levels on Effector Mechanisms of EGFR Antibodies 2012 ·The Journal of Immunology ·Stefanie Derer, (unknown), Stefan Lohse, Andreas H. Scheel, Sven Berger, Christian Kellner, Matthias Peipp, Thomas Valerius	58
18	Oncogenic KRAS Impairs EGFR Antibodies' Efficiency by C/EBPβ-Dependent Suppression of EGFR Expression 2012 ·Neoplasia ·Stefanie Derer, Sven Berger, (unknown), Tanja Schneider‐Merck, Katja Klausz, Stefan Lohse, Marije B. Overdijk, Michael Dechant, Christian Kellner, Iris Nagelmeier, Andreas H. Scheel, Jeroen J. Lammerts van Bueren, Jan G. J. van de Winkel, Paul W.H.I. Parren, Matthias Peipp, Thomas Valerius	18
19	Complement‐mediated tumor‐specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII) 2011 ·Cancer Science ·Katja Klausz, Sven Berger, Jeroen J. Lammerts van Bueren, Stefanie Derer, Stefan Lohse, Michael Dechant, Jan G. J. van de Winkel, Matthias Peipp, Paul W.H.I. Parren, Thomas Valerius	26
20	Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage 2009 ·The Journal of Immunology ·Tanja Schneider‐Merck, Jeroen J. Lammerts van Bueren, Sven Berger, (unknown), Patrick H.C. van Berkel, Stefanie Derer, Thomas Beyer, Stefan Lohse, Wim K. Bleeker, Matthias Peipp, Paul W.H.I. Parren, Jan G. J. van de Winkel, Thomas Valerius, Michael Dechant	167

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact